[email protected] +91 9789129171
ICCBO · Registering as Listener

International Conference on Cancer Biology and Oncogenesis

18 - 19 Feb 2027 Shanghai, China Standard / Physical Participation
Listener Registration
$125
virtual · $155 in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.


Coupon code

Have a code? Apply it here — the discount updates the total immediately.


Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceICCBO
ModeStandard / Physical
ParticipationListener
Registration fee$155.00
Bank charges (5.8%)$8.99
Total payable$163.99
Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

+91 9789129171

Benefits of Registering as Listener

Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
• Conference Session Tracks •
SDGs
SDG-Aligned Research Themes

ICCBO conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 9 - Industry, Innovation and Infrastructure SDG 10 - Reduced Inequalities
01 Oncogenesis and Cancer Stem Cells +
This track will explore the mechanisms of oncogenesis and the role of cancer stem cells in tumor initiation and progression. Research highlighting the implications of these findings for targeted therapies will be emphasized.
02 Malignant Transformation and Mutagenesis +
This session will focus on the processes of malignant transformation and the genetic and environmental factors that contribute to mutagenesis. Presentations will include novel insights into the molecular pathways involved in these phenomena.
03 Advances in Cancer Medical Research +
This track will showcase cutting-edge research in cancer medical science, including innovative diagnostic and therapeutic strategies. Emphasis will be placed on translational research that bridges laboratory findings with clinical applications.
04 Molecular Oncology and Analytics +
This session will delve into the latest advancements in molecular oncology, focusing on the integration of analytics in understanding cancer biology. Discussions will include the use of big data and bioinformatics in cancer research.
05 Cancer Health Disparities +
This track will address the disparities in cancer incidence, treatment, and outcomes among different populations. Research aimed at understanding and mitigating these disparities will be a central theme.
06 Innovations in Cancer Treatment and Management +
This session will highlight novel approaches in cancer treatment and management, including personalized medicine and combination therapies. The focus will be on improving patient outcomes through innovative strategies.
07 Clinical Management of Cancer +
This track will cover best practices in the clinical management of cancer patients, including multidisciplinary approaches to care. Case studies and clinical trials will be discussed to illustrate effective management strategies.
08 Cancer Immunology and Therapeutics +
This session will explore the intersection of immunology and oncology, focusing on the development of immunotherapeutic strategies. Research on the mechanisms of immune evasion by tumors will also be presented.
09 Viral Oncology and Cancer Pathogenesis +
This track will investigate the role of viral infections in cancer pathogenesis, including mechanisms of viral oncogenesis. Studies on prevention and therapeutic interventions targeting viral-associated cancers will be featured.
10 Environmental Carcinogens and Cancer Prevention +
This session will examine the impact of environmental carcinogens on cancer risk and the strategies for cancer prevention. Research on public health initiatives and policy implications will be discussed.
11 Chemical Therapeutics and Cancer Imaging +
This track will focus on the development of chemical therapeutics and advancements in cancer imaging technologies. Presentations will cover novel agents and imaging techniques that enhance diagnosis and treatment monitoring.